Compare Hyatt Hotels Corporation (H) vs Illumina, Inc. (ILMN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Hyatt Hotels Corporation vs Illumina, Inc. — how do they compare? Hyatt Hotels Corporation trades at $161.94 (market cap $15.02B), while Illumina, Inc. trades at $278.17 (market cap $39.95B). The key difference: Illumina, Inc. is far larger — about 2.7× Hyatt Hotels Corporation's market cap, and Hyatt Hotels Corporation pays a 0.38% dividend while Illumina, Inc. pays none. Which is the better fit depends on your goals — on Pluang, investors hold Hyatt Hotels Corporation for 148 Days and Illumina, Inc. for 83 Days on average.
| H | ILMN | |
|---|---|---|
Market Cap | $15.02B | $39.95B |
Volume | 842,340 | 3,169,503 |
Sector | Consumer Cyclical | Health |
52-Week High | $202.09 | $293.69 |
52-Week Low | $135.42 | $91.00 |
Typical Hold Time | 148 Days | 83 Days |
Enterprise Value | $18.93B | $41.31B |
Dividend Yield | 0.38% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Hyatt Hotels (H) trades at $159.43, up 1.46% on the day, with a neutral technical signal and bearish moving averages. Recent quarters show consistent earnings beats, but 2025 net income was negative $52 million. The company is expanding its portfolio and announced a strategic loyalty collaboration with Delta Air Lines. Analyst consensus is a Moderate Buy with a $197.77 price target, implying 24% upside.
The outlook is mixed: strong fee growth and brand expansion support long-term value, but high P/E of 196.83 and recent negative cash flow pose risks. Investor sentiment is cautiously optimistic, though valuation remains a concern amid competitive pressures in the hospitality sector.
Illumina (ILMN) trades at $264.40, down 1.25% on the day but remains near its 52-week high of $278.99, reflecting strong momentum with a 94.9% YTD gain. The company has beaten earnings estimates for three consecutive quarters, with Q3 2026 results pending. Fundamentals show a significant turnaround, with net income reaching $850 million in 2025 after prior losses, supported by robust gross margins of 66.38%. Technical indicators are bullish overall, with key support at $257 and resistance at $268.
The outlook for ILMN is positive, driven by earnings momentum, inclusion in the S&P 500, and strategic AI initiatives in genomics. However, risks include high valuation multiples, such as a P/E of 49.36, and potential margin pressure from cost volatility. Analyst consensus is bullish with a 54% buy rating, though the consensus price target of $241 suggests limited near-term upside from current levels.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Hyatt Hotels Corporation
Hyatt is an operator of 1,162 owned (5% of total rooms) and managed and franchise (95%) properties across roughly 20 upscale luxury brands, which includes vacation brands (Apple Leisure Group, Hyatt Ziva and Hyatt Zilara), the recently launched full-service lifestyle brand Hyatt Centric, the soft lifestyle brand Unbound, and the wellness brand Miraval. Hyatt acquired Two Roads in November 2018 and Apple Leisure Group in 2021. The regional exposure as a percentage of total rooms is 66% Americas, 18% Asia-Pacific, and 16% rest of world.
Read more on H →About Illumina, Inc.
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (less than 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
Read more on ILMN →
